China Diabetes Drugs Market Research Report 2016

November 2016 | 117 pages | ID: C0E754F666DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Diabetes Drugs

Revenue, means the sales value of Diabetes Drugs

This report studies Diabetes Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Lantus
• NovoLog
• Humalog
• Levemir
• Actos

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Human insulins and analogues
• Alpha-glucosidase inhibitors
• Biguanides
• DPP-4 inhibitors
• Meglitinides
• Sulphonylureas
• Thiazolidinediones

Split by Application, this report focuses on consumption, market share and growth rate of Diabetes Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

China Diabetes Drugs Market Research Report 2016

1 DIABETES DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Diabetes Drugs
1.2 Diabetes Drugs Segment by Type
  1.2.1 China Production Market Share of Diabetes Drugs Type in 2015
  1.2.2 Human insulins and analogues
  1.2.3 Alpha-glucosidase inhibitors
  1.2.4 Biguanides
  1.2.5 DPP-4 inhibitors
  1.2.6 Meglitinides
  1.2.7 Sulphonylureas
  1.2.8 Thiazolidinediones
1.3 Applications of Diabetes Drugs
  1.3.1 Diabetes Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size (Value) of Diabetes Drugs (2011-2021)
1.5 China Diabetes DrugsStatus and Outlook
1.6 Government Policies

2 CHINA DIABETES DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 China Diabetes Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Diabetes Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Diabetes Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Diabetes Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Diabetes Drugs Market Competitive Situation and Trends
  2.5.1 Diabetes Drugs Market Concentration Rate
  2.5.2 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers

3 CHINA DIABETES DRUGS MANUFACTURERS PROFILES/ANALYSIS

3.1 Lantus
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Diabetes Drugs Product Type, Application and Specification
    3.1.2.1 Type I
    3.1.2.2 Type II
  3.1.3 Lantus Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 NovoLog
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 117 Product Type, Application and Specification
    3.2.2.1 Type I
    3.2.2.2 Type II
  3.2.3 NovoLog 117 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Humalog
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 129 Product Type, Application and Specification
    3.3.2.1 Type I
    3.3.2.2 Type II
  3.3.3 Humalog 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Levemir
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Oct Product Type, Application and Specification
    3.4.2.1 Type I
    3.4.2.2 Type II
  3.4.3 Levemir Oct Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Actos
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Product Type, Application and Specification
    3.5.2.1 Type I
    3.5.2.2 Type II
  3.5.3 Actos Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview

4 CHINA DIABETES DRUGS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Diabetes Drugs Capacity, Production and Growth (2011-2016)
4.2 China Diabetes Drugs Revenue and Growth (2011-2016)
4.3 China Diabetes Drugs Production, Consumption, Export and Import (2011-2016)

5 CHINA DIABETES DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Diabetes Drugs Production and Market Share by Type (2011-2016)
5.2 China Diabetes Drugs Revenue and Market Share by Type (2011-2016)
5.3 China Diabetes Drugs Price by Type (2011-2016)
5.4 China Diabetes Drugs Production Growth by Type (2011-2016)

6 CHINA DIABETES DRUGS MARKET ANALYSIS BY APPLICATION

6.1 China Diabetes Drugs Consumption and Market Share by Application (2011-2016)
6.2 China Diabetes Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 DIABETES DRUGS MANUFACTURING COST ANALYSIS

7.1 Diabetes Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Diabetes Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Diabetes Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA DIABETES DRUGS MARKET FORECAST (2016-2021)

11.1 China Diabetes Drugs Capacity, Production, Revenue Forecast (2016-2021)
11.2 China Diabetes Drugs Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China Diabetes Drugs Production Forecast by Type (2016-2021)
11.4 China Diabetes Drugs Consumption Forecast by Application (2016-2021)
11.5 Diabetes Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Diabetes Drugs
Figure China Production Market Share of Diabetes Drugs by Type in 2015
Figure Product Picture of Human insulins and analogues
Table Major Manufacturers of Human insulins and analogues
Figure Product Picture of Alpha-glucosidase inhibitors
Table Major Manufacturers of Alpha-glucosidase inhibitors
Figure Product Picture of Biguanides
Table Major Manufacturers of Biguanides
Figure Product Picture of DPP-4 inhibitors
Table Major Manufacturers of DPP-4 inhibitors
Figure Product Picture of Meglitinides
Table Major Manufacturers of Meglitinides
Figure Product Picture of Sulphonylureas
Table Major Manufacturers of Sulphonylureas
Figure Product Picture of Thiazolidinediones
Table Major Manufacturers of Thiazolidinediones
Table Diabetes Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure China Diabetes Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Table China Diabetes Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Diabetes Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Diabetes Drugs Capacity of Key Manufacturers in 2015
Figure China Diabetes Drugs Capacity of Key Manufacturers in 2016
Table China Diabetes Drugs Production of Key Manufacturers (2015 and 2016)
Table China Diabetes Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Diabetes Drugs Production Share by Manufacturers
Figure 2016 Diabetes Drugs Production Share by Manufacturers
Table China Diabetes Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Diabetes Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Diabetes Drugs Revenue Share by Manufacturers
Table 2016 China Diabetes Drugs Revenue Share by Manufacturers
Table China Market Diabetes Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Diabetes Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Diabetes Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Diabetes Drugs Product Type
Figure Diabetes Drugs Market Share of Top 3 Manufacturers
Figure Diabetes Drugs Market Share of Top 5 Manufacturers
Table Lantus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantus Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lantus Diabetes Drugs Market Share (2011-2016)
Table NovoLog Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NovoLog Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure NovoLog Diabetes Drugs Market Share (2011-2016)
Table Humalog Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Humalog Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Humalog Diabetes Drugs Market Share (2011-2016)
Table Levemir Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Levemir Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Levemir Diabetes Drugs Market Share (2011-2016)
Table Actos Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actos Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Actos Diabetes Drugs Market Share (2011-2016)
Figure China Diabetes Drugs Capacity, Production and Growth (2011-2016)
Figure China Diabetes Drugs Revenue (Million USD) and Growth (2011-2016)
Table China Diabetes Drugs Production, Consumption, Export and Import (2011-2016)
Table China Diabetes Drugs Production by Type (2011-2016)
Table China Diabetes Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Diabetes Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Diabetes Drugs by Type
Table China Diabetes Drugs Revenue by Type (2011-2016)
Table China Diabetes Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Diabetes Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Diabetes Drugs by Type
Table China Diabetes Drugs Price by Type (2011-2016)
Figure China Diabetes Drugs Production Growth by Type (2011-2016)
Table China Diabetes Drugs Consumption by Application (2011-2016)
Table China Diabetes Drugs Consumption Market Share by Application (2011-2016)
Figure China Diabetes Drugs Consumption Market Share by Application in 2015
Table China Diabetes Drugs Consumption Growth Rate by Application (2011-2016)
Figure China Diabetes Drugs Consumption Growth Rate by Application (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetes Drugs
Figure Manufacturing Process Analysis of Diabetes Drugs
Figure Diabetes Drugs Industrial Chain Analysis
Table Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2015
Table Major Buyers of Diabetes Drugs
Table Distributors/Traders List
Figure China Diabetes Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Diabetes Drugs Revenue and Growth Rate Forecast (2016-2021)
Table China Diabetes Drugs Production, Import, Export and Consumption Forecast (2016-2021)
Table China Diabetes Drugs Production Forecast by Type (2016-2021)
Table China Diabetes Drugs Consumption Forecast by Application (2016-2021)